YOLFTbeta
Bio Preventive Medicine Corp.

Bio Preventive Medicine Corp.

6810 · TWO · Healthcare / Biotechnology

22.20TWD-0.50 (-2.20%)

Price History

Full chart

Market Stats

Previous Close22.70
Open22.70
Day Range21.70 – 22.80
52-Week Range16.50 – 46.00
Volume69.92K
Market Cap1.02B
P/E (TTM)0.00
Forward P/E0.00
EPS-1.99
Dividend Yield0.00%
50-Day Avg21.37
200-Day Avg22.44

About

Bio Preventive Medicine Corp., a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It also provides DNlite test, a series of patented and clinically validated non-invasive urine test for monitoring the progression of diabetic nephropathy, including DNlite-IVD103 and DNlite-DN_Score. Bio Preventive Medicine Corp. was founded in 2014 and is headquartered in Zhubei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • HeadquartersNo.18, Taiyuan Street, Zhubei, Taiwan, 302, Taiwan
  • Websitehttps://www.bpmbiotech.com

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--872.00K2.18M1.21M12.30M2.63M
Growth (%)---+149.66%-44.51%+917.96%-78.64%
Cost of Revenue-21.23M99.00K229.00K8.37M440.00K323.00K
Gross Profit--21.23M773.00K1.95M-7.16M11.86M2.30M
Gross Margin--88.65%89.48%-592.55%96.42%87.70%
Operating Expense-43.87M67.75M72.76M65.41M97.62M102.97M
Operating Income-72.12M-65.10M-66.97M-70.81M-72.56M-85.76M-100.67M
Operating Margin---7680.62%-3252.69%-6006.95%-697.44%-3832.05%
EBITDA-51.87M-43.22M-45.61M-53.75M-62.34M-76.56M-89.98M
EBITDA Margin---5230.62%-2469.13%-5160.68%-622.60%-3425.35%
Net Income--64.83M-67.23M-70.94M-73.28M-87.56M-99.85M
Net Income Margin---7709.52%-3258.61%-6066.64%-712.04%-3800.80%
R&D-47.06M43.87M31.62M40.54M46.89M48.93M
R&D as % of Total Revenue--5030.62%1452.32%3355.79%381.29%1862.58%
Interest Expense-388.00K252.00K929.00K2.70M3.02M2.65M
Interest Expense % of Total Revenue--28.90%42.67%223.76%24.57%100.99%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-221.48M152.83M273.12M264.66M529.71M425.19M
Total Liabilities-19.71M14.90M132.58M124.73M122.61M117.94M
Total Equity-201.77M137.94M140.54M139.93M407.09M307.24M
Cash-127.27M28.43M81.93M81.64M352.71M250.57M
Total Debt-12.73M5.74M121.90M113.45M107.31M-
Net Debt--114.54M-22.69M39.97M31.81M-245.40M-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-40.83M-46.23M-44.83M-54.63M-62.90M-66.95M-94.72M
Investing Cash Flow-4.68M-22.79M-50.65M-81.02M-933.00K-591.00K-
Financing Cash Flow74.94M76.27M-3.37M189.15M63.55M338.62M-
Capital Expenditure4.37M277.00K3.15M152.66M1.76M615.00K1.93M
Free Cash Flow-45.20M-46.50M-47.98M-207.29M-65.66M-67.57M-96.65M
FCF to OCF110.70%100.60%107.02%379.45%104.38%100.92%102.04%

Key Statistics & Ratios

Market Cap1.02B
Enterprise Value908.83M
Trailing P/E0.00
Forward P/E0.00
Price / Sales329.76
Price / Book3.88
EPS-1.99
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding49.45M
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%